India's Pharmaceutical Exports
India supplies affordable medicines to over 200 countries. This platform maps every dimension of that trade — by destination, by product, by company, by regulation — using official government data.
FY 2025–26 · Source: DGCIS, US Census, Eurostat, HMRC, RBI
Explore
The $31B picture — global trends, category mix, growth trajectory, top destinations, and year-on-year performance of India's pharma exports.
Coming soon
Deep profiles for each destination — trade volumes, growth, product mix, category breakdown, and Indian pharmaceutical investment footprint.
178 profiles
India's pharma champions mapped by global footprint — overseas investments, manufacturing sites, and market reach across continents.
Coming soon
Market access barriers, tariff structures, non-tariff measures, and registration requirements by destination — the regulatory landscape for Indian pharma.
Coming soon
CDMO capacity, API production, formulation hubs — India's pharmaceutical manufacturing ecosystem and its global competitive position.
Coming soon
Country Profiles
Each profile combines DGCIS export data with partner-country import statistics where available, creating the most complete picture of India's pharmaceutical trade with each market.
Full country index coming with mass regeneration. Showing sample profiles.
About
phrma.in is built on official government trade statistics — not estimates, not projections, not surveys. Every number traces to a source: India's Directorate General of Commercial Intelligence and Statistics (DGCIS), the US Census Bureau, Eurostat, HMRC, Statistics Canada, and the Reserve Bank of India.
Where a destination country publishes its own import data (the "mirror" or "partner" statistics), we show both sides. Partner data often captures shipments that DGCIS misses, and vice versa — dual-source profiles give the most complete picture available.
Data is updated as source agencies publish. The platform is designed for trade policy professionals, industry analysts, and export promotion bodies who need accurate, granular, and current intelligence on India's pharmaceutical trade.